Safety of DAVANAT With and Without 5-Fluorouracil in Patients With Solid Tumors - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Safety of DAVANAT With and Without 5-Fluorouracil in Patients With Solid Tumors

This study has been completed.

Study NCT00054977 Information provided by Pro-Pharmaceuticals

First Received: February 14, 2003 Last Updated: December 18, 2006 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Colorectal Cancer
Lung Cancer
Breast Cancer
Head and Neck Cancer
Prostate Cancer

Additional conditions recognized in this trial

Breast Neoplasms
Colorectal Neoplasms
Head and Neck Neoplasms
Lung Neoplasms
Prostatic Neoplasms

Interventions listed in this trial

DAVANAT
5-fluorouracil

Additional drug interventions recognized in this trial

Fluorouracil

More general drug interventions related to this trial

Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses

Sponsors listed in this trial

Pro-Pharmaceuticals

Back to top of Main Content